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Diabetes is a condition in which there is an elevation of blood glucose. Insulin, which is
produced by the pancreas, is an important hormone needed by the body because it enables
glucose to be transported into cells. Under the diabetic condition, the cells may not respond
properly to insulin or the body does not produce a sufficient amount of insulin, or both.
This situation will cause glucose accumulation in the blood that leads to major compli-
cations. Oral insulin therapy has been used for many years; however, coagulation in an
acidic environment decreases the efficacy of insulin by neutralizing its actions. Several
researchers have found that camel milk can be an adjunct to insulin therapy. It appears to
be safe and effective in improving long-term glycemic control. Therefore, the aim of this
study was to review in vivo studies on the effect of camel milk as a potential therapy for
controlling diabetes and its complications such as high cholesterol levels, liver and kidney
disease, decreased oxidative stress, and delayed wound healing.
Copyright © 2015, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC.
 
Open access under CC BY-NC-ND license.1. Introduction
Diabetes mellitus (DM) is a disease characterized by a high
level of blood sugar (i.e., glucose) that results from the failure
of the body to produce sufficient insulin (type 1 diabetes) or
from the inability to respond properly to the insulin that has
been produced by the pancreas (type 2 diabetes) [1]. The global
prevalence of DM for all age groups was estimated at 2.8% in
2000, and is expected to rise to 4.4% in 2030 [2]. Amajor part of
this increase is expected to occur in Third World countries
with the number of diabetics increasing to 35% in 2025 amongty of Science, King Abdul
.
ministration, Taiwan. Publthose aged 20 years or older. Hyperglycemia is a metabolic
disorder (i.e., the circulating blood glucose level is excessive in
the blood plasma) that results from defects in insulin secre-
tion, insulin action, or both. The function of insulin is to lower
the level of blood glucose, which occurs especially after eating.
Chronic hyperglycemia is associated with long-term damage
and with the dysfunction and failure of various organsd
especially the eyes, heart, nerves, kidneys, and blood vessels;
it is linked with hypertension [3]. However, metabolic control
can be improved through diet and physical activity with or
without antidiabetes drugs, which significantly decrease the
risk of complications [4].aziz University, P.O. Box 80203, Jeddah 21589, Saudi Arabia.
ished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
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minor population in harsh and arid parts of Africa and Asia. It
is common practice in these regions to recommend the con-
sumption of camelmilk in its fresh state or its sour state [5] for
the general treatment of diabetes [6]. It is different from the
milks of other ruminants in that it does not form coagulum in
an acidic environment [7]. This is attributed to the low degree
of phosphorylation of the caseins in camel milk [5,7]. From a
nutritional point of view, camel milk has a low cholesterol
content and its fat primarily consists of polyunsaturated fatty
acids that are completely homogenized and gives the milk a
smooth white appearance [6]. The lactose in camels milk ex-
ists in concentrations of 4.8%, but this milk sugar is surpris-
ingly easily metabolized by people who have lactose
intolerance [8]. A possible explanation for this is that camel
milk produces less casomorphin, which provokes less intes-
tinal motility; this would cause lactose to be more exposed to
the action of lactase [9]. Camel milk contains a low amount of
b-lactoglobulin [10,11] and b-casein [11]. Because these two
protein components are responsible for allergies, camel milk
has little or no allergic effects [12]. Furthermore, camel milk
has higher antibacterial and antiviral properties than cow
milk. This is partially because of the higher concentration of
lactoferrin in camel milk (220 mg/L) than in cowmilk (110 mg/
L) and the higher concentration of lysozyme in camel milk
(288 mg/100 mL) than in cow milk (13 mg/100 mL) [12e14]. In
addition, camel milk has a higher level of lactoperoxidase,
immunoglobulin G, and secretory immunoglobulin A with
antimicrobial activity [12e14], and higher vitamin C content
[15,16]. Various research studies have been performed to
examine the efficiency of camel milk to treat diabetes. The
objective of this research was to review in vivo studies on the
effect of camel milk as a potential therapy for controlling
diabetes (type 1) and its complications such as high choles-
terol level, liver and kidney disease, decreased oxidative
stress, and delayed wound healing.2. Antihyperglycemic effect of camel milk
Diabetes mellitus is a serious disease with multiple compli-
cations that is rising dramatically worldwide. Three-fourths of
the world population cannot afford allopathic medicine and
thus has to rely on naturopathic medicine, which is basically
derived from natural products of animals and plants [17].
Once diabetic patients start insulin therapy, they have to take
it permanently and usually insulin dose continue to increase
as time progresses. Clinical research on the use of camel milk
by patients with type 1 diabetes has indicated that drinking
camel milk daily decreases the blood glucose level and re-
duces insulin requirement by 30% [18]. It appears that camel
milk provides an insulin-like protein in a different form than
in other mammals and/or delivers some other therapeutic
compounds that boosts the health of diabetic patients. How-
ever, the mechanism is not yet fully understood. Mucosal
surfaces are a common and suitable route for delivering drugs
such as peptides and proteins to the body. However, the oral
administration of insulin is incapable of overcoming mucosal
barriers and is degraded by digestive enzymes before it enters
the bloodstream [19]. As a unique feature of camel milk, theinsulin-like protein could be protected in the stomach and
absorbed efficiently into blood stream to reach the target. This
is because camel milk does not coagulate in an acidic envi-
ronment and it has a higher buffering capacity than the milk
of other ruminants [13]. In addition, since no differences noted
in the sequence of camel milk insulin-like protein and its
digestion pattern compared to other sources of milk to over-
come the mucosal barriers, camel milk insulin-like protein
could be protected in the stomach by nanoparticles (e.g., lipid
vesicles) to reach the target [20]. Camel milk also contains
approximately 52 micro unit/ml of insulin-like protein
compared to cow milk (16.32 micro unit/ml) which mimic in-
sulin interaction with its receptor, and it has a higher content
of zinc [21] which has a key role in insulin secretory activity in
pancreatic beta cells. Beg et al [22] found that the amino acid
sequence of some camel milk protein is rich in half cystine,
which has a superficial similarity with the insulin family of
peptides. In addition, compared to milk from other mamma-
lian species, camel milk possesses a different casein content,
a higher amount of polyunsaturated fatty acids (C18:1eC18:3),
larger lipid micelles, and a higher amount of vitamin B3
[23,24]. Furthermore, the small size and weight of camel milk
immunoglobulin may offer enormous potential through
interaction with the host cell protein and cause an induction
of regulatory cells and finally result in a downward regulation
of the immune system and b-cell salvage [18,25]. Some re-
searchers suggest that the insulin-like protein in camel milk
has the ability to resist proteolytic digestion, which makes its
absorption into circulation faster than insulin-like protein
from other milk sources (Fig. 1).
A previous study shows that raw camel milk has
the ability to reduce blood glucose level by 55% in diabetic
rats, compared to raw cattle milk (43%) [15]. Agrawal et al [26]
studied the hypoglycemic activity of raw and pasteurized
camel milk in streptozotocin (STZ)-induced diabetic rats.
Based on the results, the blood glucose levels in diabetic
rats treated with raw camel milk decreased from
169.68 ± 28.7 mg/dL to 81.54 ± 11.4 mg/dL (p < 0.02) after
4 weeks of treatment, whereas diabetic rats treated with
pasteurized camel milk showed a slight decrease from
135.45 ± 20.91 mg/dL to 113 ± 29.09 mg/dL (Table 1)
[13,14,26e30]. A new study was conducted by Sboui et al [27]
to evaluate the effect of camel milk administered for 5 weeks
to alloxan-induced diabetic dogs. A significant reduction in
the level of blood glucose from 10.88 ± 0.55 mmol/L to
5.77 ± 0.44 mmol/L occurred in dogs treated with 500 mL of
camel milk for 5 weeks (Table 1). The effect of camel milk in
comparison with biosynthetic insulin treatment in experi-
mentally induced diabetes in rabbits was investigated by El-
Said et al [14]. They found that the mean serum insulin
level was significantly higher (7.9 ± 0.9 mIU/mL) for diabetic
rabbits treated with camel milk for 4 weeks than for un-
treated diabetic rabbits and insulin-treated diabetic rabbits
(2.4 ± 0.1 mIU/mL and 5.6 ± 0.4 mIU/mL, respectively). In dia-
betic rabbits, treatment with camel milk was able to lower
the glucose level more greatly than biosynthetic insulin
(Table 1). Al-Numair et al [28] report the antihyperglycemic
effect of camel milk on STZ-induced diabetic rats. They
found that STZ-diabetic rats that were fed camel milk at the
optimum dose of 250 mL/d for 45 days showed a significant
Fig. 1 e The properties of camel milk insulin-like proteins.
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to 141.57 ± 12.82 mg/dL. In addition, a higher plasma level of
insulin (p < 0.05) was present in STZ-diabetic rats treated
with camel milk, compared to untreated diabetic rats
(Table 1). A significant reduction (p < 0.05) in blood glucose
levels (approximately 30%) has been reported in diabetic rats
treated with camel milk for 6 weeks [29]. However, the blood
glucose levels in diabetic rats treated with cow or buffalo
milk showed an improvement of only 12% or 10%, respec-
tively [29]. A similar study was conducted by Khan et al [30] to
study the possible antidiabetic effects of camel milk in STZ-
induced diabetic rats. They report that the blood glucose
levels of diabetic rats that were fed fresh camel milk reduced
significantly from 560 mg/dL to 235 mg/dL after 30 days
(Table 1). Streptozotocin-induced diabetic mice treated with
camel milk whey protein displayed a significant reduction in
blood glucose levels from 411 ± 37 mg/dL to 261 ± 25.5 mg/dL
after 2 weeks [31]. Throughout the period of study, diabetic
mice treated with camel milk whey protein had significantly
higher levels of insulin, compared to untreated diabetic mice
(Table 1).
Agrawal et al [32] found camel milk had a significant hy-
poglycemic effect when administered to type 1 diabetic pa-
tients as an adjunct therapy for 3 months (Table 2)
[18,32,33,35e37]. At the end of 3 months, they observed a
significant decrease in insulin doses that were required to
achieve glycemic control, and a significant enhancement in
hemoglobin A1c level. The mean dose of insulin required
before camel milk treatment in the type 1 diabetic patients
was 41.16 ± 10.32 units/d. This value gradually reduced to a
mean level of 30 ± 12.06 units/d (p < 0.002) during 3 months of
treatment [32]. In 2005, Agrawal et al [33] determined the
long-term efficacy and safety of camel milk as an adjunct to
insulin therapy in patients with type 1 diabetes after 1 year.
The mean blood glucose level decreased from 119 ± 19 mg/dL
to 95.42 ± 15.70 mg/dL (p < 0.005) and the mean doses of in-
sulin reduced significantly throughout the study period
(Table 2). Another study by Agrawal et al [18] involved 50
newly diagnosed type 1 diabetic patients who were divided
in two groups of 25 patients: one group received conventional
treatment and the other group consumed 500 mL of
fresh camel milk in addition to receiving conventional med-
ical treatment for 12 months. The mean blood sugar level in
the camel milk-consuming group reduced from115.16 ± 14.50 mg/dL to 100.20 ± 17.40 mg/dL, compared to
the control group (114.40 ± 17.70 mg/dL to 104.00 ± 15.87 mg/
dL). In addition, the requirement of the daily mean dose of
insulin reduced from 30.40 ± 11.97 units/d to 19.12 ± 13.39
units/d in the camel milk-consuming group (Table 2). By
contrast, the control group showed no significant difference
in the mean dose of insulin required after 1 year. This
observation was in agreement with another study conducted
by Agrawal et al [34], who reported zero prevalence of DM in
the camel milk-consuming Raica community of northwest
Rajasthan, India. They stated that people consuming camel
milk showed significantly less crude prevalence of DM (0.4%),
compared to people who did not consume camel milk (5.5%).
Agrawal et al [35] reported a significant reduction (p < 0.01) in
the mean dose of insulin in type 1 diabetic patients that was
required to obtain glycemic control after 6 months of camel
milk treatment (from 41.61 ± 3.08 mg/dL to 28.32 ± 2.66 mg/
dL). Mohamad et al [36] evaluated the efficacy of camel milk
as an adjuvant therapy in young type 1 diabetic patients for
16 weeks. Fifty-four type 1 diabetic patients (average age, 20
years) were divided into two groups of 27 patients in which
the first group (i.e., the control) was treated by the usual
management (i.e., diet, exercise, and insulin) and the second
group was treated with 500 mL camel milk and the usual
management. They found a significant difference between
the control group and camel milk group after 16 weeks. After
16 weeks of treatment, the fasting blood sugar was decreased
from 227.2 ± 17.7 mg/dL to 98.9 ± 16.2 mg/dL, and the
required daily insulin dose was reduced from 48.1 ± 6.95
units/d to 23 ± 4.05 units/d. An earlier study reports that
camel milk in combination with insulin can be an effective
supplementation as an adjunctive therapy in controlling pa-
tients with type 1 diabetes, compared to camel milk alone or
insulin injection alone [37]. The reduction of fasting blood
glucose in type 1 diabetic patients treated with camel milk
and insulin was approximately 28% after 3 months,
compared to 22% or 11% of patients treated with camel milk
alone or insulin alone, respectively (Table 2). Furthermore,
the combination of camel milk and insulin reduced the
postprandial blood glucose in type 1 diabetic patients by 52%,
compared to camel milk alone (30%) or insulin alone (12%)
[37]. Some researchers suggest that camel milk can be safely
consumed by nondiabetic people or by healthy people
[30,38,39].
Table 1 e Antihyperglycemic effect of camel milk in vivo in animal models.
Refs Diabetogenic Model of
study
Dosages
(daily)
Duration Blood glucose
before
Blood glucose
after
Insulin p *
Agrawal
et al [13]
STZ (50 mg/kg body weight by
intraperitoneal administration)
Rats
(N ¼ 32)
250 mL (raw camel milk) 3 wk 191.33 ± 7.46 mg/dL 86.25 ± 12.77 mg/dL * ND < 0.05
250 mL (raw cattle milk 110.0 ± 9.97 mg/dL *
Agrawal
et al [26]
STZ (50 mg/kg body weight by
intraperitoneal administration)
Rats
(N ¼ 40)
25 mL (raw camel milk) 4 wk 169.69 ± 28.73 mg/dL 81.54 ± 11.43 mg/dL* ND < 0.02
25 mL (pasteurized camel
milk)
135.45 ± 20.91 mg/dL 113.08 ± 29.09 mg/dL* < 0.5
Sboui
et al [27]
Alloxan (65 mg/kg dissolved in
normal saline at a concentration of
100 mg/mL) by intravenous
administration)
Dogs
(N ¼ 12)
500 mL (raw camel milk) 5 wk 10.88 ± 0.55 mmol/L 5.77 ± 0.44 mmol/L * ND < 0.05
El-Said
et al [14]
Alloxan (90 mg/kg dissolved in
5 mL of normal saline) via the ear
vein
Rabbits
(N ¼ 40)
7 mL/kg of raw camel milk 4 wk 528.4 ± 28.2 mg/dL 116.6 ± 11.9 mg/dL * [ From 2.4 ± 0.1 to
7.9 ± 0.9 mU/mL*
< 0.05
Biosynthetic human insulin
(HuNil) 1.5 IU/kg
205.7 ± 15 mg/dL * [ From 2.4 ± 0.1 to
5.6 ± 0.4 mU/mL*
Al-Numair
et al [28]
STZ (40 mg/kg body weight by
intraperitoneal administration)
Rats
(N ¼ 30)
250 mL (raw camel milk) 45 d 292.38 ± 19.20 mg/dL 141.57 ± 12.82
mg/dL*
[ From 5.53 ± 0.41 to
9.97 ± 0.80 mU/mL*
< 0.05
Hamad
et al [29]
STZ (60 mg/kg body weight by
intraperitoneal
Rats
(N ¼ 30)
20 mL camel milk þ 95 g
basal diet
6 wk 146 ± 9.8 mg/dL 101 ± 9.7 mg/dL * ND < 0.05
20 mL cow milkþ 95 g basal
diet
200 ± 11.1 mg/dL 176 ± 8.9 mg/dL *
20 mL buffalo milkþ 95 g
basal diet
197 ± 10.1 mg/dL 177 ± 9.0 mg/dL *
Khan
et al [30]
STZ (55 mg/kg body weight by
intraperitoneal administration)
Rats
(N ¼ 40)
400 mL of raw camel milk 4 wk 520.46 ± 8.90 mg/dL 235.61 ± 7.10 mg/dL * ND < 0.05
Badr [31] STZ (60 mg/kg body weight by
intraperitoneal administration)
Mouse
(N ¼ 30)
Undenatured camel milk
whey protein (100 mg/kg of
body weight)
2 wk 411 ± 37 mg/dL 261 ± 25.5 mg/dL * [ From 1.7 ± 0.15 to
3.3 ± 0.3 ng/mL*
<0.05
* ¼ The level of significance at p value when compared with data before treatment.
[ ¼ increase; ND ¼ not detected; STZ ¼ streptozotocin.
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Diabetes isassociatedwithprofoundvariations inplasma lipids,
triglycerides, and lipoprotein profile, and is responsible for
vascular complications and an increased risk of heart disease
[40,41]. Thus, lowering the cholesterol levels through dietary or
drug therapy seems to be associatedwith a reduced risk of heart
disease [42]. Low-density lipoprotein-C (LDL-C) in the human
body circulation undergoes reuptake in the liver through
particular receptors and is thereby cleared from the circulation
[43]. The elevation of LDL levels in the plasma of diabetic pa-
tients can be the result of a defect in the LDL-C receptor (i.e.,
failure in production or function). High-density lipoprotein-C
(HDL-C) is protective by reversing cholesterol transport, inhib-
iting the oxidation of LDL-C, and neutralizing the atherogenic
effects of oxidized LDL-C [39]. There is a correlation between the
level of very-low-density lipoprotein-C (VLDL-C) and HDL-C. A
significant increase in LDL-C and VLDL-C levels may lead to a
significant decrease in HDL-C levels. In addition, lower HDL-C
levels can also occur because of reduced activity in lecithin-
cholesterol acyltransferase (LCAT) [39]. A previous study
shows that the administration of camel milk can help decrease
the levels of cholesterol in diabetic patients [32,36,37,43].
In one study [27], alloxan-induced diabetic dogs treated
with camel milk (Group 1) showed a statistically significant
decrease (p < 0.05) in the total cholesterol (TC) level from
6.17 ± 0.15 mmol/L to 4.35 ± 0.61 mmol/L after 5 weeks. In this
period, diabetic dogs treated with cow milk (Group 2) showed
an increase in the TC level from 5.99 ± 0.58 mmol/L to
7.13 ± 1.25 mmol/L (Table 3) [14,27,30,39,44]. However, the
diabetic dogs in Group 2 were treated with camel milk instead
of cow milk for the next 5 weeks, and showed a 30%
improvement in the TC level. Furthermore, diabetic dogs from
Group 1 showed an improvement in lipid profile even after 5
weeks of having stopped drinking camel milk [27]. Al-Numair
[39] reported that the administration of camel milk is able to
reduce hyperlipidemia that is associated with the risk of DM.
This study found TC, triacylglycerols (TG), free fatty acid (FFA),
phospholipids (PLs), LDL-C, and VLDL-C levels significantly
decreased (p < 0.05) towards normal levels in plasma and
tissues (e.g., liver, kidney, and heart), whereas the plasma
HDL-C significantly improved in diabetic rats after treatment
with camel milk for 45 days (Table 3). Another study con-
ducted by El-Said et al [14] to evaluate the effect of camel milk
on lipid profile in experimentally induced diabetic rabbits was
not in agreement with the previous study (Table 3). However,
the group of diabetic rabbits treatedwith camelmilk showed a
significant (p < 0.05) reduction in the TG level from
603.4 ± 9.6 mg/dL to 524.8 ± 14.2 mg/dL after 1 month. To
evaluate the protective role of camel milk against dyslipide-
mia, changes in the lipid profile levels were analyzed in STZ-
induced diabetic rats in one study [30]. The results of this
study indicated that the levels of TC, TG, and LDL-C were
significantly higher (p < 0.05) in the control group of diabetic
rats and these levels were significantly reduced in the group of
rats fed camel milk (Table 3). Other researchers recently
studied the hypocholesterolemic effect of Gariss (i.e., fer-
mented camel milk) on the levels of lipid profile of rats [44].
They observed that TG, TC, HDL, and VLDLþLDL were
Table 3 e Antihyperlipidemic effect of camel milk in in vivo animal models.
Refs Dosages
(daily) &
duration
No. of
sample
Duration TG TC PLs HDL-C LDL-C VLDL-C FFA p *
El-Said et al [14] 7 mL/kg of
raw camel
milk
Rabbits
(N ¼ 40)
4 wk Y From 603.4
± 9.6 to 524.8
± 14.2 mg/dL
[ From 274.2
± 6.6 to 295.9
± 7.9 mg/dL
[ From 214.5
± 41.3 to 364.2
± 38.4 mg/dL
Y From 52.1
± 1.0 to 36.4
± 3.8 mg/dL
[ From 119.7
± 0.4 to 168.8
± 0.4 mg/dL *
ND ND < 0.05*
Sboui et al, [27] 500 mL of
raw camel
milk
Dogs
(N ¼ 12)
5 wk From 1.03
± 0.17 to 1.03
± 0.3 mmol/L
YFrom 6.17
± 0.5 to 4.35
± 0.61 mmol/L
ND ND ND ND ND < 0.05*
500 mL of
raw cow
milk
[ From 1.03
± 0.17 to 1.14
± 0.33 mmol/L
[ From 5.99
± 0.58 to 7.13
± 1.25 mmol/L
Al-Numair [39] 250 mL
raw camel
milk
Rats
(N ¼ 30)
45 d Y From 157.19
± 14.14 to 116.40
± 6.34 mg/dL
Y From 169.81
± 10.24 to 98.28
± 6.36 mg/dL
Y From 160.99
± 11.62 to 103.66
± 9.33 mg/dL
[ From 34.60
± 2.57 to 39.03
± 2.19 mg/dL
Y From 32.23
± 2.82 to 24.08
± 1.26 mg/dL *
Y From 105.97
± 7.81 to 38.16
± 3.25 mg/dL *
Y From 140.48
± 10.46 to 80.69
± 5.63 mg/dL *
< 0.05*
Khan et al [30] 400 mL of
raw camel
milk
Rats
(N ¼ 40)
4 wk Y From 167.43
± 5.8 to 109.23
± 6.3 mg/dL
Y From 298.31
± 12.4 to 196.27
± 11.9 mg/dL
ND Y From 58.43
± 6.8 to 52.37
± 5.6 mg/dL
Y From 191.31
± 8.4 to 128.34
± 5.9 mg/dL *
ND ND < 0.05*
Ali et al [44] Fermented
camel milk
(Gariss) diet
formula
Rats
(N ¼ 24)
6 wk Y From 144.27
± 4.47 to 68.25
± 3.30 mg/100 mL
YFrom 135.79
± 8.74 to 87.93
± 4.00 mg/100 mL
ND [ From 11.66
± 1.29 to 28.78
± 1.07 mg/100 mL
ND ND ND < 0.05*
* ¼ The level of significance at p value when compared with data before treatment.
FFA¼ free fatty acid; HDL-C¼ high-density lipoprotein-C; LDL-C¼ low-density lipoprotein-C; ND¼ not detected; PLs¼ phospholipids; TC¼ total cholesterol; TG¼ triacylglycerols; VLDL-C¼ very-low-
density lipoprotein-C.
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tively, in a group of rats fed a cholesterol-enriched diet sup-
plemented with Gariss for 6 weeks, compared to the control
group fed only a cholesterol-enriched diet (Table 3).
An earlier study has shown that no significant changes
occurred in the lipid profile after 3 months in diabetic patients
(type 1) treated with camel milk [32]. However, Agrawal et al
[35] found a significant reduction of LDL-C and TG in type 1
diabetic patients after being treated with camel milk for 6
months (Table 4) [32,35e37]. By contrast, no significant dif-
ferences in TC, HDL-C, and VLDL levels were shown in diabetic
patients after being treated with camel milk (Table 4). Moha-
mad et al [36] showed the efficiency of camel milk as an
adjuvant therapy on the lipid profile of young type 1 diabetic
patients. The TC and TG level in type 1 diabetics decreased by
25% and 37%, respectively, after treatmentwith camelmilk for
16 weeks; however, there were no significant differences in
HDL, LDL, and VLDL levels after treatment [36]. El-Sayed et al
[37] investigated the effect of insulin provided by camel's milk
on the lipid profile of type 1 diabetics in comparison with in-
sulin injection alone or camel milk alone. After 3 months, the
lipid profile in the type 1 diabetic patients injectedwith insulin
(i.e., the control group) decreased the levels of TG and TC by
9% and LDL-C by 7% (Table 4). The lipid profile conversely
decreased significantly (p < 0.001) by three-fold for TG and by
two-fold for TC and LDL-C in diabetic patients treated with
camelmilk (Table 4). The diabetic patient group treated with a
mixture of insulin and camel milk showed a significant
reduction (p < 0.001) in TG and TC (approximately 45%) and
LDL-C (approximately 30%), compared to control. In addition,
the HDL-C level increased significantly (p < 0.001) from 41mg/
dL to 49 mg/dL in patients treated with the mixture [37].T
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;4. The effects of camel milk on liver and
kidney function
The prevalence of liver disease and increased liver enzyme
levels is common in people with DM. Elevation in the levels of
liver enzymes such as alanine aminotransferase (ALT) and
aspartate aminotransferase (AST) in diabetic patients reflect
the concentration of intracellular hepatic enzymes that have
leaked into the circulation and serve as a marker of hepato-
cyte injury [45]. The beneficial health effects of camel milk
were extended to the liver and kidney function. Hamad et al
[29] found a significant development in liver function pa-
rameters (e.g., ALT and AST activities) appeared within dia-
betic rat groups treatedwith camel, cow, and buffalomilk. The
greatest improvement was seen in rats fed camel milk: 41%
improvement for ALT and 38% improvement for AST. Khan
et al [30] evaluated the effects of camel milk on liver function
of STZ-induced diabetic rats. The results of their study
showed that feeding rats camel milk for 1 month results in a
dramatic shift towards a normal level of liver enzymes (ALT
and AST) in STZ-induced diabetic rats.
Diabetic nephropathy is originally microvascular in nature
and is widely considered an important complication of dia-
betes. Albuminuria is a well-known predictor of poor renal
outcomes [46]. Microalbuminuria (i.e., urine albumin) is
defined as levels of albumin ranging 30e300 mg in a 24-hour
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 3 ( 2 0 1 5 ) 6 0 9e6 1 8616urine collection [47]. Camel milk has potential role in con-
trolling microalbuminuria levels in type 1 diabetic patients
[35]. A significant reduction (p < 0.001) in microalbuminuria
levels has been reported (from 119.48 ± 1.68 mg/dL to
22.52 ± 2.68 mg/dL) in type 1 diabetic patients after adding
camel milk to the usual diet for 6 months. Mohamad et al [36]
similarly found that the microalbuminuria level decreased
from 92.08 ± 15.18 to 75.75 ± 3.17 after 24 hours in type 1
diabetic patients treated with camel milk. Furthermore, kid-
ney function parameters (e.g., levels of uric acid, urea, and
creatinine) were enhanced significantly to the normal level in
diabetic rats fed camel milk [29,30].5. Effect of camel milk on oxidative stress in
diabetes
Oxidative stress and its subsequent damage happen when
antioxidant defense mechanisms fail to efficiently counter
endogenous or exogenous sources of reactive oxygen species
(ROS) [48]. Increased oxidative stress may contribute to DM
and to the development of vascular and neurologic compli-
cations of the disease [49]. Thus, the control of ROS production
is required for physiologic cell function. Reactive oxygen
species in cells are neutralized by antioxidant defense
mechanisms such as the enzymes superoxide dismutase
(SOD), catalase, and glutathione peroxidase. The existence of
hyperglycemia may induce the increased production of ROS
via nonenzymatic glycation, glucose autoxidation, and alter-
ations in polyol pathway activity with subsequent influence
on the whole organism [48]. The most important indicators of
oxidative stress are the increased level of lipid peroxidation
products and in specific malondialdehyde [50].
Low levels of antioxidant enzymes increase the vulnera-
bility to oxidative stress owing to reduced antioxidant defense
mechanisms. This results in the damaging effects of free
radicals that could have an essential role in DM. Furthermore,
increased oxidative stress in diabetic patients reduces the
levels of nonenzymatic antioxidants such as glutathione,
vitamin E, and vitamin C [51], which subsequently damages
metabolic pathways and may contribute to the development
of diabetic complications.
The protective effects of camelmilkmay be attributed to its
antioxidant activity [52e55] and probably has chelating effects
on toxicants [24]. It has been reported that camel milk pos-
sesses high levels of vitamins (e.g., A, B2, C, and E) and is rich
in mineral content (e.g., sodium, potassium, copper, magne-
sium, and zinc) [24,56]. The aforementioned vitamins are an-
tioxidants that are useful in preventing tissue injury
associated with toxic agents such as STZ [57]. In addition, the
high minerals content in camel milk [56] may act as antioxi-
dant, and thereby remove free radicals [58e60]. Because
camels prefer grazing on natural vegetationdin particular,
desert bushes, salty plants, and herbsdtheir diet may provide
some of the phytochemicals excreted in camel milk and give
additional benefit to diabetic patients treatedwith camelmilk.
El-Said et al [14] evaluated the effect of camel milk on
oxidative stress in induced diabetic rabbits. The diabetic rab-
bits group treated with camel milk showed significant im-
provements (p < 0.05) in the levels of malondialdehyde,catalase, and glutathione (5.6 ± 0.3 nmol/mL, 377.5 ± 4.2 U/L,
and 10.1 ± 0.7 mg/dL, respectively), compared to untreated
diabetic rabbits (8.7 ± 0.2 nmol/L, 204.7 ± 17.9 U/L, and
8.6 ± 0.6 mg/dL, respectively). Because SOD is decreased in
diabetes as a result of its consumption during the conversion
of superoxide anions into hydrogen peroxide (H2O2), which
prevents the cells from further generating free radicals [61].
Camel milk showed the ability to increase SOD in diabetic
rabbits [16], diabetic mice [31], and autistic children [62].6. The effect of camel milk on wound healing
process in diabetes
Wound healing is a normal biological process in the human
body. This healing process is commonly classified into four
phases: hemostasis, inflammation, proliferation, and remod-
eling. A successful wound healingmust pass all four phases in
the accurate sequence and time frame. Improper or impaired
wound healing can occur by certain factors such as desicca-
tion, infection or abnormal bacterial presence, maceration,
necrosis, pressure, trauma, and edema [63].
Delayedwoundhealing occurs inpatientswith diabetes and
is one of the most serious diabetes-associated complications.
The main factors for improper or impaired wound healing in
diabeticpatientsare thepresenceof replicatingorganismssuch
as bacteria within the wound. Milk whey proteins accelerate
woundhealing indiabetics by enhancing the immune response
of wounded tissue cells and by alleviating some diabetic com-
plications [31]. Camel milk contains a varied group of proteins
such as serum albumin, a-lactalbumin, immunoglobulin, lac-
tophorin, and peptidoglycan recognition protein [64]. Recent
studies have indicated that camel milk increases the antioxi-
dant activity in thebodyand showeda therapeutic effect on the
treatment of oxidative stress-associated diseases [16,62].
Badr [31] demonstrated that camel milk whey proteins
significantly reduced the wound size in treated STZ-induced
diabetic mice for 1 month. This result was correlated with
various histopathological findings such as increased epitheli-
zation activity, angiogenesis, granulation tissue formation, and
extracellular matrix remodeling. Hydroxyproline is a primary
component in collagen. A significant restoration of hydroxy-
proline content has been reported after the oral administration
of camelmilkwheyproteins indiabeticmice [31]. The increased
level of collagen may strengthen the regenerate tissue in dia-
betic mice. The previous finding was in agreement with Al-
Numair et al [28] who found that treatment with camel milk
elevated the levels ofhydroxyproline and total collagen content
towards normal level in the tail tendon of STZ-diabetic rats.7. Conclusion
Based on evidence-based reviews of research findings on the
use of camel milk in diabetes management, it can be
concluded that camel milk has a powerful effect in reducing
blood glucose levels and insulin requirement, and it limits
diabetic complications such as elevated cholesterol levels,
liver and kidney diseases; decreased oxidative stress; and
delayed wound healing. Camel milk is safe and efficient in
j o u r n a l o f f o o d and d ru g an a l y s i s 2 3 ( 2 0 1 5 ) 6 0 9e6 1 8 617improving long-term glycemic control and can provide a sig-
nificant reduction in the dose of insulin required by type 1
diabetic patients. Therefore, the daily consumption of camel
milk may reduce the risk of diabetes. Camel milk is able to
pass through the acidic environment of the stomach and be
absorbed into the blood stream. Therefore, it can be included
in the preparation of oral insulin to avoid coagulation in the
stomach that occurs in milk from other mammalian sources.
In addition, further studies are needed to isolate the actual
bioactive peptides in camel milk that are similar in producing
the insulin effect and responsible for reducing blood glucose
in diabetes. Furthermore, fermentation of camel milk in the
presence of probiotic bacteria could increase the potential
therapy of camelmilk to control diabetes. Thus, further in vitro
and in vivo studies are highly recommended.Conflicts of interest
The author declares no conflicts of interest.r e f e r e n c e s
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